Mild Cognitive Impairment Clinical Trial
Official title:
Effect of Heat Exposure on Cognition in Persons With Higher Cord Lesions
The ability to maintain normal body temperature (Tcore) is impaired in persons with
tetraplegia: subnormal Tcore and vulnerability to hypothermia (<95 F) have been documented in
this population after exposure to even mild environmental temperatures. However, no work to
date has addressed the effect of subnormal Tcore on cognitive performance in persons with
tetraplegia despite studies with able-bodied (AB) individuals that have documented
progressive decline in various aspects of cognitive performance associated with the magnitude
of the depression in Tcore. The investigators' study will confirm and extend their initial
observations in persons with higher cord lesions who have subnormal Tcore to show that
cognitive performance will be improved by raising Tcore to euthermic levels. This improvement
should be associated with greater function and independence, reintegration into society, and
an improved quality of life.
Specific Aims: During exposure to 95 F for up to 120 minutes in the seated position, the
investigators' aims are:
Primary Specific Aim: To determine if a modest rise in Tcore to euthermic levels has a
positive effect on cognitive performance (attention, working memory, processing speed, and
executive function) in persons with higher-level spinal cord injury (SCI).
Primary Hypothesis: Based on the investigators' pilot data: (1) 80% of persons with SCI will
demonstrate an increase of 1 F in Tcore, while none of the AB controls will demonstrate such
an increase; (2) 80% of persons with SCI will have an improvement of at least one T-score in
Stroop Interference scores (a validated measure of executive function), while none of the AB
controls will demonstrate a change in cognitive performance.
Secondary Specific Aim: To determine changes in: (1) The average of distal skin temperatures;
(2) Sweat rate; and (3) Subjective rating of thermal sensitivity.
Secondary Hypothesis: Persons with SCI will have less of a percent change in average distal
skin temperatures and sweat rate, and will report blunted ratings of thermal sensitivity
compared to that of AB controls.
This study will investigate the physiological and cognitive responses to warm exposure in
persons with SCI who have subnormal Tcore and in AB persons who are euthermic. The positive
effect that an increase in Tcore will be expected to have on cognitive performance,
specifically working memory and executive function, will be demonstrated. These two areas of
cognitive performance are vital for the ability to optimally care for one's self, at which
persons with higher cord lesions must excel in order to ensure health, and for the ability to
attain the maximal degree of independence possible.
Preparation for Study Visits: Subjects will be instructed to avoid caffeine and alcohol,
maintain normal salt and water intake, and avoid strenuous exercise for 24 hours prior to the
study. Subjects will be asked to eat a light, standard meal (plain bagel or 2 pieces of
toast) 2 hours prior to their visit. Subjects will be asked to empty their bladders prior to
their visit and again upon arrival, if needed. Subjects will wear minimal clothing during the
study to maximize skin exposure to the warm temperature.
Instrumentation: Subjects with SCI will be asked to remain in their wheelchairs and AB
controls will be placed in a manual wheelchair where they will remain seated and relatively
still for the duration of the study visit. A thin, flexible rectal sensor will be placed 4
inches beyond the anal sphincter for Tcore collection, and skin sensors will be secured at 15
sites above and below the level of lesion for collection of skin temperature (Tsk). Sweat
collection capsules will be placed on the left bicep, the left forearm, the left thigh and
the left calf for measurement of sweat rate by QSweat methodology (QS). Laser Doppler
flowmetry will be used to measure changes in microvascular perfusion (MVP) by placing a
Doppler probe on the back of both hands and both feet to confirm peripheral blood vessel
dilation. An automated blood pressure cuff will be placed above the left elbow to measure
brachial BP.
Baseline Collection (BL): At the end of a 30-minute acclimation period at 81 F, a baseline
collection of the following parameters will be performed for 15 minutes: Tcore and Tsk will
be continuously monitored; BP, heart rate (HR), and thermal sensitivity (TS) will be measured
in 10-minute intervals; and MVP and QS will be measured in 15-minute intervals. After 15
minutes, a battery of cognitive tests will be administered to establish baseline cognitive
performance.
Thermal Challenge (Heat): Following completion of the BL period, subjects will be wheeled
into a pre-heated (95 F) thermal chamber for up to 120 minutes or until Tcore increases 1 F.
Tcore and Tsk will be continuously monitored to ensure subjects' safety throughout the
protocol, while HR, BP, and TS will be assessed at 10-minute intervals. MVP and QS will be
measured every 30 minutes. The battery of cognitive tests utilized during BL collection will
be administered when Tcore increases 1 F from BL values (for subjects with tetraplegia) or
after 100 minutes (for controls) to determine any change in cognition after exposure to 95 F.
An increase in Tcore 1 F, significant changes in BP, or subject discomfort will result in
termination of the protocol.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |